Top advances of the year in colorectal cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34185
Abstract: Over the past year, studies have demonstrated better ways of using the agents that we have to improve outcomes for patients with colon and Rectal cancers. read more here.
Keywords: top advances; year; cancer top; advances year ... See more keywords
Top advances of the year: Pediatric oncology
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34425
Abstract: Accelerated discovery and collaborative research continue to highlight the remarkable progress that has been made in the diagnosis and treatment of pediatric cancers. This manuscript highlights important discoveries on how precision oncology is being incorporated… read more here.
Keywords: oncology; top advances; pediatric oncology; advances year ... See more keywords
Top advances of the year: Leukemia
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34619
Abstract: In the year 2021, there were three new Food and Drug Administration approvals for all leukemia types: asciminib (Scemblix) for chronic myeloid leukemia, brexucabtagene autoleucel (Tecartus) for relapsed/refractory B‐cell acute lymphocytic leukemia, and asparaginase erwinia… read more here.
Keywords: top advances; leukemia; advances year; brexucabtagene autoleucel ... See more keywords
Top advances of the year: Hepatobiliary cancers
Sign Up to like & getrecommendations! Published in 2023 at "Cancer"
DOI: 10.1002/cncr.34652
Abstract: This commentary reviews top advances in hepatobiliary cancer research in 2021–2022, focusing on leveraging immunotherapeutics in combination with other therapies earlier in the disease course and targeted to patient's individualized biomarkers that may predict response… read more here.
Keywords: hepatobiliary cancers; top advances; year hepatobiliary; advances year ... See more keywords
Top advances of the year: Neuro‐oncology
Sign Up to like & getrecommendations! Published in 2023 at "Cancer"
DOI: 10.1002/cncr.34711
Abstract: Management of brain tumors has been challenging given the limited therapeutic options and disabling morbidities associated with central nervous system (CNS) dysfunction. This review focuses on recent developments in the field, with an emphasis on… read more here.
Keywords: oncology; top advances; brain tumors; year neuro ... See more keywords